Phibro Animal Health Corp DEF 14A Filing
Ticker: PAHC · Form: DEF 14A · Filed: Sep 20, 2024 · CIK: 1069899
| Field | Detail |
|---|---|
| Company | Phibro Animal Health Corp (PAHC) |
| Form Type | DEF 14A |
| Filed Date | Sep 20, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Phibro Animal Health Corp's DEF 14A is out, detailing exec pay and equity awards for FY24.
AI Summary
Phibro Animal Health Corp filed a DEF 14A on September 20, 2024, for the fiscal year ending November 5, 2024. The filing details executive compensation and other corporate governance matters. Key financial periods covered include fiscal years 2021 through 2024, with specific data points related to equity awards granted and outstanding.
Why It Matters
This filing provides crucial information for investors regarding executive compensation and corporate governance, impacting shareholder decisions and company oversight.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and corporate governance, not indicating immediate financial distress or significant new risks.
Key Numbers
- 20241105 — Fiscal Year End (Reporting period for the filing)
- 20240920 — Filing Date (Date the document was submitted to the SEC)
Key Players & Entities
- PHIBRO ANIMAL HEALTH CORP (company) — Filer
- 0001069899 (company) — Central Index Key
- 201-329-7300 (dollar_amount) — Business Phone
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
What fiscal years are covered by the financial data in this filing?
The filing includes financial data for fiscal years 2021-07-01 to 2024-06-30, 2022-07-01 to 2023-06-30, and 2021-07-01 to 2022-06-30.
What is Phibro Animal Health Corp's Standard Industrial Classification (SIC) code?
Phibro Animal Health Corp's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Phibro Animal Health Corp headquartered?
Phibro Animal Health Corp's business and mailing address is Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666.
When was the company formerly known as PhilBrothers Chemicals Inc.?
The company was formerly known as PhilBrothers Chemicals Inc. and its name change date was 19980908.
Filing Stats: 4,840 words · 19 min read · ~16 pages · Grade level 11.5 · Accepted 2024-09-20 16:16:11
Filing Documents
- pahc-20241105xdef14a.htm (DEF 14A) — 1562KB
- pahc-20241105xdef14a_a003.jpg (GRAPHIC) — 14KB
- pahc-20241105xdef14a_a004.jpg (GRAPHIC) — 5KB
- pahc-20241105xdef14a_a019.jpg (GRAPHIC) — 65KB
- pahc-20241105xdef14a_a020.jpg (GRAPHIC) — 63KB
- pahc-20241105xdef14a_a021.jpg (GRAPHIC) — 64KB
- pahc-20241105xdef14a_a022.jpg (GRAPHIC) — 44KB
- pahc-20241105xdef14a_bg001.jpg (GRAPHIC) — 159KB
- pahc-20241105xdef14a_cg001.jpg (GRAPHIC) — 105KB
- 0001558370-24-012924.txt ( ) — 3936KB
- pahc-20241105.xsd (EX-101.SCH) — 7KB
- pahc-20241105_def.xml (EX-101.DEF) — 51KB
- pahc-20241105_lab.xml (EX-101.LAB) — 5KB
- pahc-20241105_pre.xml (EX-101.PRE) — 5KB
- pahc-20241105xdef14a_htm.xml (XML) — 356KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 31 2024 Summary Compensation Table 31 All Other Compensation 33 Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards in Fiscal Year 2024 34 Individual Arrangements 39 Treatment of Equity Awards and Long-Term Cash Awards Upon Termination or a Change in Control 41 Potential Payments Upon Termination or a Change in Control 41 CEO PAY RATIO 44 PAY VERSUS PERFORMANCE 45 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 50 Registration Rights Agreements 50 Employment Arrangements 50 Indemnification Agreements 50 Policies and Procedures With Respect to Related Party Transactions 50 AUDIT COMMITTEE REPORT 51
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 52 EQUITY COMPENSATION PLAN INFORMATION 54 STOCKHOLDERS PROPOSALS OR NOMINATIONS TO BE PRESENTED AT NEXT ANNUAL MEETING 54 OTHER MATTERS 55 2024 Annual Report and SEC Filings 55 ii Table of Contents PHIBRO ANIMAL HEALTH CORPORATION PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held at 9:00 A.M. Eastern Time on Tuesday, November 5, 2024 This proxy statement and the enclosed form of proxy card are furnished in connection with the solicitation of proxies by our Board of Directors (the "Board of Directors" or "Board") for use at the 2024 Annual Meeting of Stockholders of Phibro Animal Health Corporation, a Delaware corporation, and any postponements, adjournments or continuations thereof (the "Annual Meeting"). The Annual Meeting will be held on Tuesday, November 5, 2024, at 9:00 A.M. Eastern Time, at the Company's offices located at Glenpointe Centre East, 3 rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666. The Notice of Internet Availability of Proxy Materials (the "Notice"), containing instructions on how to access this proxy statement and our annual report, is first being mailed on or about September 23, 2024 to all stockholders of record as of September 13, 2024 (the "Record Date"). Only stockholders of record as of the Record Date will be entitled to vote at the Annual Meeting. The information provided in the "question and answer" format below is for your convenience only and is merely a summary of the information contained in this proxy statement. You should carefully read this proxy statement in its entirety. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this proxy statement and references to our website address in this proxy statement are inactive textual references only. As used in this proxy statement, the terms "Phibro," "Company," "we," "us" and "our" mean Phibro An